Recruiting
Phase 3

Whole-Body Acceleration

Sponsor:

Center for Translational Medicine

Code:

NCT01629810

Conditions

Pain

Stiffness

Abnormal Gait

Balance

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Whole body periodic acceleration (Exer-Rest)

Study Details

Brief summary:

The purpose of this study is to test the effectiveness of whole body periodic acceleration for helping with symptoms of aches and pains suffered by many patients.

Conditions

Pain

Stiffness

Abnormal Gait

Balance

Study ID

NCT01629810

Start date

Aug, 2011

Status verified date

Jun, 2012

Primary completion date

Aug, 2013

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

Subjects qualifying for this study satisfy the following criteria:

1. Over 18 years of age;
2. Complain of either chronic pain, joint stiffness, and/or dysfunctions of gait and balance;
3. Complaints have been annotated by a competent physician, and the subject has been evaluated for conditions that commonly contribute to the respective symptoms;
4. Capable of completing the appropriate testing and baseline assessments, such as quantitative electroencephalography (qEEG) and questionnaires;
5. Tolerate the motion and duration of treatment of the WBPA.
6. Be available for regular visits to the research site for the duration of the study.

Exclusion Criteria:

WBPA is contraindicated for subjects who are pregnant or who suffer with unexplained leg pain, skin eruptions, or who have unstable spinal injuries or conditions. Subjects who cannot tolerate the motion and duration of treatment are also excluded.

Study Design

Enrollment

30 participants

Anticipated

Intervention Model

Crossover

Primary purpose

Treatment

Interventions and Outcome Measures

Interventions

Whole body periodic acceleration (Exer-Rest)

Lying on the vibrating bed for 45 minutes per session for 10 sessions over 2 weeks.

Primary outcome measure

  • Self-report of pain [ Time Frame: 2 weeks ]

Central Contacts and Locations

Locations

Translational Medicine Group

Recruiting

Bethesda, Maryland, United States, 20852

Contacts

Karen P Walters, MSN

240-221-0000kpw@tmgmd.com

Principal Investigator:

Stephen N Xenakis, M.D.

More Information

Sponsor

Center for Translational Medicine

Last update posted

Jun 28, 2012

Last verified

Jun, 2012

Keywords

  • Motion platform at appropriate settings.
  • Relief of pain.
  • Improvement in quality of life, cognition, and mood.
  • Effects of WBPA on cognition, mood, behavior, and functioning.
  • Dose response effect .
  • Gather data for long-term (2 year) study

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Center for Translational Medicine on 2012-06-28.